Ad is loading...
PRLAX vs TRZYX
PRLAX vs TRZYX Comparison
Open Charts PRLAX vs TRZYX
T. Rowe Price Latin America
Price$16.84
Change-$0.40 (-2.32%)
VolumeN/A
Net Assets311.39M
T. Rowe Price Latin America Z
Price$16.68
Change-$0.39 (-2.28%)
VolumeN/A
Net Assets311.39M
PRLAX vs TRZYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
PRLAX (311M) and TRZYX (311M) have equal amount of cash in the bank . TRZYX pays higher dividends than PRLAX: TRZYX (5.25) vs PRLAX (3.22). PRLAX was incepted earlier than TRZYX: PRLAX (31 years) vs TRZYX (4 years). PRLAX (1.46) is less costly to investors than TRZYX (1.15). PRLAX (23.20) and TRZYX (23.20) have comparable annual turnover. TRZYX has a lower initial minimum investment than PRLAX: TRZYX (0) vs PRLAX (2500). TRZYX annual gain was more profitable for investors over the last year : -17.30 vs. PRLAX (-18.41).
| PRLAX | TRZYX | PRLAX / TRZYX | |
| Total Expense Ratio | 1.46 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.46 | 1.15 | 127% |
| Fund Existence | 31 years | 4 years | - |
| Gain YTD | 6.223 | 6.621 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 311M | 311M | 100% |
| Annual Yield % from dividends | 3.22 | 5.25 | 61% |
| Returns for 1 year | -18.41 | -17.30 | 106% |
| Returns for 3 years | -13.03 | -9.19 | 142% |
| Returns for 5 years | 47.68 | N/A | - |
| Returns for 10 years | -3.70 | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MRJSX | 10.31 | -0.28 | -2.64% |
| Morgan Stanley Multi-Asset Real ReturnR6 | |||
| RPFRX | 38.71 | -1.81 | -4.47% |
| Davis Real Estate A | |||
| FIJCX | 84.93 | -4.84 | -5.39% |
| Fidelity Advisor Consumer Staples Z | |||
| JAGLX | 62.80 | -3.76 | -5.65% |
| Janus Henderson Global Life Sciences T | |||
| MFVZX | 15.41 | -0.93 | -5.69% |
| MassMutual Equity Opports I | |||